CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net loss	$ (486,761)	$ (519,510)	$ (578,979)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	60,923	51,739	55,950
Stock-based compensation	948,087	524,803	340,817
Impairment charges for leases and leasehold improvements	61,098	0	7,526
Deferred income taxes	10,613	(2,002)	(8,860)
Gain on a non-cash sale of a controlling interest of a subsidiary	(45,158)	0	0
Net loss on exchange derivative and capped call transactions	0	424,482	616,446
Amortization of debt discount and issuance cost	471	27,051	86,572
Net loss (gain) on strategic investments	19,407	72,663	(48,080)
Net foreign currency loss (gain)	(10,613)	(12,065)	7,595
Other	1,488	646	1,381
Changes in operating assets and liabilities:
Accounts receivable, net	(169,526)	(134,764)	(61,256)
Prepaid expenses and other assets	(38,230)	(21,927)	(10,054)
Accounts payable	78,902	31,741	10,441
Accrued expenses and other liabilities	74,611	93,250	76,090
Deferred revenue	362,799	284,937	294,371
Net cash provided by operating activities	868,111	821,044	789,960
Cash flows from investing activities:
Business combinations, net of cash acquired	(5,775)	(19,411)	(91,769)
Purchases of intangible assets	(160)	(4,018)	(1,800)
Purchases of property and equipment	(25,652)	(70,583)	(31,520)
Purchases of strategic investments	(19,450)	(111,668)	(10,250)
Purchases of marketable securities and other investments	(24,800)	(21,003)	(109,181)
Proceeds from maturities of marketable securities	73,950	76,937	454,996
Proceeds from sales of marketable securities and strategic investments	629	186,262	48,786
Net cash provided by (used in) investing activities	(1,258)	36,516	259,262
Cash flows from financing activities:
Proceeds from term loan facility	0	1,000,000	0
Payment of issuance costs for debt	0	0	(4,445)
Repayment of exchangeable senior notes	0	(1,548,686)	(1,803,244)
Proceeds from settlement of capped call transactions	0	135,497	203,093
Repurchases of Class A Common Stock	(150,006)	0	0
Proceeds from other financing arrangements	1,585	13,909	1,163
Net cash used in financing activities	(148,421)	(399,280)	(1,603,433)
Effect of foreign exchange rate changes on cash and cash equivalents	(1,805)	(9,233)	5,408
Net increase (decrease) in cash, cash equivalents, and restricted cash	716,627	449,047	(548,803)
Cash, cash equivalents, and restricted cash at beginning of period	1,386,686	931,023	1,489,143
Net decrease (increase) in cash and cash equivalents included in assets held for sale	602	6,616	(9,317)
Cash, cash equivalents, and restricted cash at end of period	2,103,915	1,386,686	931,023
Reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above:
Cash and cash equivalents	1,385,265	919,227
Restricted cash included in other non-current assets	1,365	1,421	11,796
Total cash, cash equivalents, and restricted cash	2,103,915	1,386,686	931,023
Supplemental disclosures of cash flow information:
Income taxes paid, net of refunds	102,156	66,648	50,272
Interest paid, net	28,493	13,310	6,498
Non-cash investing and financing activities:
Purchase of property and equipment included in accrued expenses and other current liabilities	844	10,740	2,440
Repurchases of Class A Common Stock included in accrued expenses and other current liabilities	4,167	0	0
Transfers from property and equipment to assets held for sale	$ 0	$ 0	$ 35,123